Logo image
International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of ADAMTS13
Journal article   Peer reviewed

International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of ADAMTS13

I. Mackie, I. Mancini, J. Muia, J. Kremer Hovinga, S. Nair, S. Machin and R. Baker
International Journal of Laboratory Hematology, Vol.42(6), pp.685-696
2020
url
Free to Read *No subscription requiredView

Abstract

This guidance document was prepared on behalf of the International Council for Standardization in Haematology (ICSH), by the ADAMTS13 Assay Working Group, which comprises an international group of both clinical and laboratory experts. The document provides recommendations on best practice for the performance of ADAMTS13 assays in clinical laboratories. ADAMTS13 assays support the differential diagnosis of thrombotic microangiopathies and have utility in the management of thrombotic thrombocytopenic purpura (TTP). There are three types of assay: activity, antigen and autoantibody/inhibitor assays. Methods for activity assays differ in terms of sensitivity, specificity, precision and turnaround time. The most widely used assays involve VWF peptide substrates and either chromogenic ELISA or FRET techniques, although chemiluminescence assays and rapid screening tests have recently become available. Tests for autoantibodies and inhibitors allow confirmation of acquired, immune‐mediated TTP, while antigen assays may be useful in congenital TTP and as prognostic markers. In this document, we have attempted to describe ADAMTS13 assays and the conditions that affect them, as well as: blood collection, sample processing, quality control, standardization and clinical utility; recognizing that laboratories in different parts of the world have varying levels of sophistication. The recommendations are based on expert opinion, published literature and good clinical laboratory practice.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

52 File views/ downloads
86 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.286 Immunology & Hematology
1.286.1746 Thrombotic Thrombocytopenic Purpura
Web Of Science research areas
Hematology
ESI research areas
Clinical Medicine
Logo image